| Cavia porcellus |
Cavia porcellus |
Activity |
nan |
None |
10.1016/j.bmcl.2012.05.034 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Activity |
6.9 |
pD2 |
10.1021/jm020099f |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
EC50 |
6.31 |
nM |
10.1016/j.bmcl.2012.05.034 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
EC50 |
6.31 |
nM |
10.1016/j.bmcl.2012.08.051 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
EC50 |
12.59 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
45.0 |
% |
10.1016/j.bmcl.2013.05.018 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
65.0 |
% |
10.1016/j.bmcl.2012.05.034 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
65.0 |
% |
10.1016/j.bmcl.2012.08.051 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
pD2 |
6.9 |
None |
10.1021/jm00013a010 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Relative efficacy |
0.2 |
None |
10.1021/jm00013a010 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
15274.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
266.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
1160.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
2045.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
2100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
310.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
920.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
5647.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
3368.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
771.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
7018.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
7361.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
6079.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Caco-2 |
Kp |
11.0 |
ucm/s |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Caco-2 |
Kp |
11.0 |
ucm/s |
10.1016/j.bmcl.2012.08.051 |
| Homo sapiens |
Caco-2 |
Kp |
11.0 |
ucm/s |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Caco-2 |
permeability |
11.0 |
10'-6 cm/s |
10.1021/jm900881j |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
2650.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
20449.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
15134.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
340.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
730.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
941.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
3100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
3500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
5620.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
656.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
1850.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
6782.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
GABA-B receptor 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
11360.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
4800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
Inhibition |
33.0 |
% |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
HERG |
Inhibition |
33.0 |
% |
10.1016/j.bmcl.2012.08.051 |
| Homo sapiens |
HERG |
Inhibition |
33.0 |
% |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
27196.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-9.42 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
1.16 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
CL |
17.6 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
18.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
18.0 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.36 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.4 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
10.0 |
% |
10.1021/jm900881j |
| Homo sapiens |
Homo sapiens |
Fa |
0.5 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.11 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.94 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.23 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
5.3 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
4900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
11518.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
5343.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
23579.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
16323.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
2320.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
2800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
6590.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide FF receptor 1 |
Activity |
nan |
None |
10.1021/jm9011998 |
| Homo sapiens |
Neuropeptide FF receptor 2 |
Activity |
nan |
None |
10.1021/jm9011998 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
11432.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
260.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
495.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
18999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10936.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
20843.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
21000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
40.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
168.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
870.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1d (5-HT1d) receptor |
Ki |
100.0 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
174.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
1500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
100.0 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
20.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
342.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
1.995 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
543.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
100.0 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
Ki |
2511.89 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
Ki |
10000.0 |
nM |
10.1016/j.bmc.2008.11.045 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
EC50 |
1.0 |
nM |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
EC50 |
1.995 |
nM |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
EC50 |
2.512 |
nM |
10.1016/j.bmcl.2012.08.051 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
EC50 |
2.512 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
EC50 |
15.85 |
nM |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
71.0 |
% |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
92.0 |
% |
10.1016/j.bmcl.2012.08.051 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
92.0 |
% |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
99.0 |
% |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Intrinsic activity |
115.0 |
% |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Ki |
3.981 |
nM |
10.1016/j.bmc.2008.11.045 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Ki |
3.981 |
nM |
10.1016/j.bmcl.2012.05.034 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Ki |
3.981 |
nM |
10.1016/j.bmcl.2012.08.051 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Ki |
3.981 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin 4 (5-HT4) receptor |
Ki |
31.0 |
nM |
10.1021/np0601760 |
| Homo sapiens |
Serotonin 5a (5-HT5a) receptor |
AC50 |
190.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
197.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
802.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
Ki |
100.0 |
nM |
10.1016/j.bmcl.2013.05.018 |
| Homo sapiens |
Serotonin transporter |
AC50 |
2570.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
3474.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
8389.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
1800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29855.4 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
21300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
20266.9 |
nM |
10.1038/s41467-023-40064-9 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3013.1 |
nM |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
24962.3 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
16000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Liver microsomes |
T1/2 |
1.5 |
hr |
10.1016/j.bmcl.2012.05.034 |
| Rattus norvegicus |
Liver microsomes |
T1/2 |
1.5 |
hr |
10.1016/j.bmcl.2013.05.018 |
| Rattus norvegicus |
Liver microsomes |
T1/2 |
1.5 |
hr |
10.1021/jm900881j |
| Rattus norvegicus |
Liver microsomes |
T1/2 |
90.0 |
hr |
10.1016/j.bmcl.2012.08.051 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
18105.6 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.02 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
2.43 |
mg kg-1 |
10.1016/j.bmcl.2013.05.018 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/acsmedchemlett.8b00035 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
21.0 |
ng.hr.mL-1 |
10.1021/jm900881j |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
19.91 |
nM |
10.1021/jm900881j |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.0106 |
mg.kg-1 |
10.1016/j.bmcl.2012.05.034 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.0106 |
mg.kg-1 |
10.1021/jm900881j |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.011 |
mg.kg-1 |
10.1016/j.bmcl.2012.08.051 |
| Rattus norvegicus |
Rattus norvegicus |
F |
5.0 |
% |
10.1021/jm900881j |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
1.8 |
hr |
10.1021/jm900881j |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
-0.04384 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.bmcl.2013.05.018 |
| None |
ADMET |
CL |
18.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
MRT |
4.9 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
11.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
5.3 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
4.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Fu |
0.02 |
None |
10.1124/dmd.108.020479 |
| None |
Unchecked |
Ac50 |
3.162 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.981 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.943 |
uM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
AC50 |
3981.1 |
nM |
None |
| None |
Unchecked |
AC50 |
7943.3 |
nM |
None |
| None |
Unchecked |
IC50 |
3131.8 |
nM |
None |
| None |
Unchecked |
IC50 |
7174.71 |
nM |
None |
| None |
Unchecked |
IC50 |
10858.56 |
nM |
None |
| None |
Unchecked |
IC50 |
16844.2 |
nM |
None |
| None |
Unchecked |
IC50 |
40000.0 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Ratio Ki |
580.0 |
None |
10.1016/j.bmcl.2012.05.034 |
| None |
Unchecked |
Ratio Ki |
580.0 |
None |
10.1016/j.bmcl.2012.08.051 |